These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3465966)

  • 1. [Two cases of null cell type acute lymphoblastic leukemia with an interesting phenotype].
    Arakawa S; Sugimoto T; Imashuku S; Iwasaku M; Matsumura T; Horii Y; Ezumi N; Shimizu Y; Hibi S; Fujiwara F
    Rinsho Ketsueki; 1986 Jul; 27(7):1069-75. PubMed ID: 3465966
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytochemical characteristics and immunologic markers in acute lymphoblastic leukemias (author's transl)].
    Dorlhiac P; Genter G; Jamra M
    Sangre (Barc); 1981; 26(4):433-8. PubMed ID: 6974901
    [No Abstract]   [Full Text] [Related]  

  • 3. [Common null antigen of acute lymphoblastic leukemia and "lymphoid" variant of the blastic phase of chronic myeloid leukemia].
    Baryshnikov AIu; Morozova LF; Volkova MA; Frinovskaia IV; Maiakova SA
    Probl Gematol Pereliv Krovi; 1982 Sep; 27(9):23-5. PubMed ID: 6757918
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characteristics of acute lymphoblastic leukemia of children with 0-cells in the bone marrow and a predominance of T- or B-cells in the peripheral blood].
    Lenskaia RV; Samochatova EV; Rumiantsev AG; Izotova TA
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):20-4. PubMed ID: 6974356
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in the management of childhood leukemia.
    Bowman WP
    Tex Med; 1985 Mar; 81(3):39-44. PubMed ID: 3885465
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methods of immune typing of blast cells in acute lymphoblastic leukemia in adults].
    Răileanu Moţoiu I; Costescu M; Dumitrescu A; Munteanu N; Ursea C; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):273-6. PubMed ID: 6140723
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. I. Acute lymphocytic leukaemia (ALL).
    Ukaejiofo EO; Sagoe AS; Osunkoya BO
    Afr J Med Med Sci; 1983; 12(3-4):187-95. PubMed ID: 6326553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis.
    Greaves MF; Janossy G; Peto J; Kay H
    Br J Haematol; 1981 Jun; 48(2):179-97. PubMed ID: 7016165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic acute lymphoblastic leukemia with helper activity.
    Fontán G; Campos A; García-Rodriguez MC; Zabay JM; Jiménez MC; de la Concha EG
    Thymus; 1983 Apr; 5(3-4):241-2. PubMed ID: 6603683
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electrophoretic mobility in acute null cell lymphoblastic leukemia].
    Pavone V; Jirillo E; Specchia G; Loria MP; Liso V
    Boll Ist Sieroter Milan; 1982; 61(3):225-9. PubMed ID: 6985423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
    Zipf TF; Fox RI; Dilley J; Levy R
    Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic and ultrastructural heterogeneity of acute lymphoblastic leukemia-associated antigen-positive human leukemias.
    LeBien TW; Parkin JL; Brunning RD; Kersey JH
    J Natl Cancer Inst; 1980 Dec; 65(6):1231-6. PubMed ID: 6933270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spontaneous immunorosette in acute lymphoblastic leukemia in children].
    Schneer JH; Mănăilă T; Naghi A
    Rev Pediatr Obstet Ginecol Pediatr; 1974; 23(4):361-6. PubMed ID: 4219650
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of acute lymphocytic leukemia cell surface markers as detected by monoclonal antibodies.
    Mann DL; Haynes BF; Thomas C; Cole D; Fauci AS; Poplack DG
    J Natl Cancer Inst; 1983 Jul; 71(1):11-7. PubMed ID: 6602900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic markers in the diagnosis of the acute lymphocytic leukemias.
    Hecht F; Hecht BK; Vyvial TM; Jarzabek V; Morgan R
    Ariz Med; 1982 Oct; 39(10):640-3. PubMed ID: 6983337
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute lymphoblastic leukaemia with B-cell phenotype.
    Basu S; Sinha AK; Bagchi DK; Swarup-Mitra S
    J Indian Med Assoc; 1985 Oct; 83(10):357-9. PubMed ID: 3879615
    [No Abstract]   [Full Text] [Related]  

  • 18. An analysis of the presence of Fc receptors on bone marrow lymphoblasts in acute lymphoblastic leukemia. A Pediatric Oncology Group study.
    Humphrey GB; Blackstock R; Falletta JM; Metzgar RS; Richie ER; Pullen DJ; Boyett JM; Shuster JJ; Roper MA; Russell EC
    Cancer; 1985 Oct; 56(8):1995-2000. PubMed ID: 3875396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological variants and treatment of lymphoblastic leukemia].
    Shalaev VA
    Gematol Transfuziol; 1986 Jul; 31(7):58-63. PubMed ID: 3527859
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunologic subclassification of lymphoblastic leukemia in childhood. I. Evaluation of immunologic phenotype].
    Kołecki P
    Acta Haematol Pol; 1986; 17(3-4):96-102. PubMed ID: 3473888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.